TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Binab Bio-Innovation AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
451
|
528
|
624 |
| Financial expenses |
11
|
1
|
2 |
| Earnings before taxes |
4
|
-10
|
14 |
| EBITDA |
25
|
7
|
44 |
| Total assets |
215
|
241
|
353 |
| Current assets |
146
|
163
|
249 |
| Current liabilities |
62
|
93
|
179 |
| Equity capital |
152
|
148
|
172 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
70.7%
|
61.4%
|
48.7% |
| Turnover per employee |
451
|
528
|
624 |
| Profit as a percentage of turnover |
0.9%
|
-1.9%
|
2.2% |
| Return on assets (ROA) |
7.0%
|
-3.7%
|
4.5% |
| Current ratio |
235.5%
|
175.3%
|
139.1% |
| Return on equity (ROE) |
2.6%
|
-6.8%
|
8.1% |
| Change turnover |
-79
|
-45
|
92 |
| Change turnover % |
-15%
|
-8%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.